Implantable Cardioverter-Defibrillator Registry Risk Score Models for Acute Procedural Complications or Death After Implantable Cardioverter-Defibrillator Implantation

被引:70
作者
Haines, David E. [1 ]
Wang, Yongfei [2 ]
Curtis, Jeptha [2 ]
机构
[1] Oakland Univ, Dept Cardiovasc Med, William Beaumont Sch Med, Beaumont Hosp,Heart Rhythm Ctr, Royal Oak, MI 48073 USA
[2] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA
关键词
complications; death; implantable cardioverter-defibrillators; outcome assessment; registries; MYOCARDIAL-INFARCTION; RANDOMIZED-TRIAL; PACEMAKER; OUTCOMES;
D O I
10.1161/CIRCULATIONAHA.110.959676
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Patients undergoing implantable cardioverter-defibrillator (ICD) implantation are at risk of postprocedural complications. However, we do not have a risk stratification schema to identify patients at high and low risk of adverse events. Methods and Results-We analyzed data from 268 701 ICD implants submitted to the ICD Registry and developed logistic regression models to identify variables most strongly associated with the risk of acute complications and/or in-hospital death. Overall, 3.2% of the population experienced an adverse event. A simple risk score consisting of 10 readily available variables successfully identified patients at high and low risk of complications. The variables included in the score and assigned points included: age >= 70 years (1 point), female (2 points), New York Heart Association class III (1 point) or IV (3 points), atrial fibrillation (1 point), prior valve surgery (3 points), chronic lung disease (2 points), blood urea nitrogen >30 (2 points), reimplantation for reasons other than battery change (6 points), ICD type dual chamber (2 points) or biventricular (4 points), and nonelective ICD implant (3 points). The risk of any in-hospital complication increased from 0.6% among patients with a score of <= 5 (8.4% of the population) to 8.4% among patients with >= 19 risk points (3.9% of the population). Conclusions-A simple risk score consisting of readily available clinical variables can identify high-and low-risk subsets of patients undergoing ICD implantation. This information can guide the physician in patient selection and determining the intensity of care required post procedure. (Circulation. 2011;123:2069-2076.)
引用
收藏
页码:2069 / 2076
页数:8
相关论文
共 50 条
  • [21] Risk of Failure of Transvenous Implantable Cardioverter-Defibrillator Leads
    Borleffs, C. Jan Willem
    van Erven, Lieselot
    van Bommel, Rutger J.
    van der Velde, Enno T.
    van der Wall, Ernst E.
    Bax, Jeroen J.
    Rosendaal, Frits R.
    Schalij, Martin J.
    [J]. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2009, 2 (04) : 411 - 416
  • [22] Depression and Implantable Cardioverter-Defibrillator Implantation in Black Patients at Risk for Sudden Cardiac Death
    Boursiquot, Brian C.
    Young, Rebecca
    Alhanti, Brooke
    Sullivan II, Lonnie T.
    Maul, Andrew J.
    Khedagi, Apurva
    Sears, Samuel F.
    Jackson II, Larry R.
    Thomas, Kevin L.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (14):
  • [23] The Timing of Implantable Cardioverter-Defibrillator Implantation in Patients with Heart Failure
    Al-Majed, Nawaf S.
    Ezekowitz, Justin A.
    [J]. CURRENT CARDIOLOGY REPORTS, 2012, 14 (03) : 299 - 307
  • [24] The Timing of Implantable Cardioverter-Defibrillator Implantation in Patients with Heart Failure
    Nawaf S. Al-Majed
    Justin A. Ezekowitz
    [J]. Current Cardiology Reports, 2012, 14 : 299 - 307
  • [25] Outcomes of subcutaneous implantable cardioverter-defibrillator implantation in patients on hemodialysis
    Koman, Eduard
    Gupta, Ashwani
    Subzposh, Faiz
    Saltzman, Heath
    Kutalek, Steven P.
    [J]. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2016, 45 (02) : 219 - 223
  • [26] Reel syndrome in a patient with an implantable cardioverter-defibrillator
    Cruz Cardentey, Marleny
    Castro Hevia, C. Jesus A.
    Castaneda Chirino, Osmin
    Falcon Rodriguez, Roywi
    Lopez Martinez, Frank
    [J]. CORSALUD, 2018, 10 (03): : 252 - 255
  • [27] Drug-implantable cardioverter-defibrillator interactions
    Beadle, Roger
    Williams, Lynne
    Lim, Hoong Sern
    [J]. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2010, 8 (09) : 1267 - 1273
  • [28] Risk and predictors of mortality after implantable cardioverter-defibrillator implantation in patients with sarcoid cardiomyopathy
    Higgins, Angela Y.
    Annapureddy, Amarnath R.
    Wang, Yongfei
    Minges, Karl E.
    Bellumkonda, Lavanya
    Lampert, Rachel
    Rosenfeld, Lynda E.
    Jacoby, Daniel L.
    Curtis, Jeptha P.
    Miller, Edward J.
    Freeman, James, V
    [J]. AMERICAN HEART JOURNAL, 2022, 246 : 21 - 31
  • [29] Subcutaneous implantable cardioverter-defibrillator in a young woman
    Calvagna, Giuseppe Mario
    Ceresa, Fabrizio
    Patane, Salvatore
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 175 (02) : E30 - E32
  • [30] Is Anyone Too Old for an Implantable Cardioverter-Defibrillator?
    Heidenreich, Paul A.
    Tsai, Vivian
    [J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2009, 2 (01): : 6 - 8